Deep Vein Thrombosis News and Research

RSS

Deep vein thrombosis, or DVT, is a blood clot that forms in a vein deep in the body. Most deep vein clots occur in the lower leg or thigh. If the vein swells, the condition is called thrombophlebitis. A deep vein thrombosis can break loose and cause a serious problem in the lung, called a pulmonary embolism, or a heart attack or stroke.

Risk of DVT on planes so small... not worth taking pills

The debate over the health risks associated with long-haul flights is in the news again with research from Holland.

25 Sep 2007

Natural aorta grafts have few side effects for infection-prone patients

A vascular surgery technique pioneered at UT Southwestern Medical Center, in which veins are removed from the thigh to repair the aorta does not create blood-flow problems and painful side effects in a majority of patients, researchers report.

11 Sep 2007

Studies assess blood clot prevalence outside hospital prevention in hospital

More cases of venous thromboembolism are diagnosed in the three months following hospitalization than during hospitalization, but less than half of inpatients receive medications to prevent blood clots from occurring, according to a report in the July 23 issue of Archives of Internal Medicine.

24 Jul 2007

FDA panel will help decide fate of drug Evista for preventing breast cancer

Before the osteoporosis drug Evista is approved for breast cancer in the U.S. the Food and Drug Administration (FDA) will take the advice of an advisory panel.

23 Jul 2007

Venous thromboembolism in the U.S.

Venous thrombosis (VTE), the formation of blood clots in a vein, is a major health problem for hospitalized patients in the United States.

16 Jul 2007

Four hours in ecomony class doubles the risk for deep vein thrombosis

According to the World Health Organization (WHO) the chances of developing deep vein thrombosis ( DVT) double after traveling for four hours or more; this says WHO equates to one in 6,000 long-haul passengers at risk of potentially dangerous blood clots.

2 Jul 2007

Folic acid may lower the risk of stroke

Researchers in the United States say folic acid supplements may reduce the risk of stroke by more than 18 percent.

4 Jun 2007

Merits and risks of postmenopausal hormone therapy

The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.

17 May 2007

Patient safety incidents at the nation's hospitals rose three percent

Patient safety incidents at the nation's hospitals rose three percent over the years 2003 to 2005, but the nation's top-performing hospitals had a 40 percent lower rate of medical errors when compared with the poorest-performing hospitals, according to the largest annual study of patient-safety issued today by HealthGrades, the leading independent healthcare ratings company.

2 Apr 2007

Impact of maternal obesity on the NHS

A new study reveals the true costs of the increase in maternal obesity and how it is impinging on service delivery in the NHS

8 Mar 2007

Tamoxifen offers long-term benefits for breast cancer prevention among women at high risk

The trials found that the breast cancer risk reduction persists long after women stop taking tamoxifen.

20 Feb 2007

New oral blood thinner

A new oral blood thinner is being compared to an old standby to see if it works as well and is easier to manage long term, researchers say.

13 Feb 2007

New breast cancer drug Exemestane shows great potential to save lives

In what will be welcome news to millions of women suffering from breast cancer, trials of a new drug have found it lowers oestrogen levels in women with hormone-sensitive breast cancer and has the potential to save more than 1,000 lives a year in the UK alone.

13 Feb 2007

Sticking to clinical guidelines decreases deep vein thrombosis in elderly

A multifaceted intervention designed to increase adherence with clinical guidelines for preventing deep-vein blood clots may decrease the rate of such blood clots among elderly patients, according to a report in the October 23 issue of Archives of Internal Medicine.

23 Oct 2006

Idaho woman files lawsuit over Ortho Evra patch

A woman in Idaho who said she developed a blood clot disorder after using the birth control patch Ortho Evra -- made by Ortho-McNeil, a subsidiary of Johnson & Johnson -- has filed a lawsuit in federal court against the companies, the AP/Houston Chronicle reports.

19 Oct 2006

FDA approves Zolinza for the treatment of cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA) has approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

8 Oct 2006